As the year got underway, biotechs were in focus among the notable insider purchases.
A well-known adage reminds us that corporate insiders and 10% owners really only buy shares of a company because they believe the stock price will rise and they want to profit from it. Thus, insider buying can be an encouraging signal for potential investors.
Remember that as a new earnings-reporting season gets underway, many insiders are prohibited from buying or selling shares. Here are some of the more notable insider purchases that were reported since the beginning of the year.
This post appeared first on 24/7 Wall St..